Purinergic responses of calcium-dependent signaling pathways in cultured adult human astrocytes

被引:21
作者
Hashioka, Sadayuki [1 ]
Wang, Yun Fan [2 ]
Little, Jonathan P. [3 ]
Choi, Hyun B. [2 ]
Klegeris, Andis [3 ]
McGeer, Patrick L. [1 ]
McLarnon, James G. [2 ]
机构
[1] Univ British Columbia, Dept Psychiat, Kinsmen Lab Neurol Res, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada
[3] Univ British Columbia Okanagan Campus, IK Barber Sch Arts & Sci, Dept Biol, Kelowna, BC, Canada
来源
BMC NEUROSCIENCE | 2014年 / 15卷
关键词
Adult human astrocytes; P2; receptors; Intracellular calcium signaling; ATP; 3 '-O-(4-benzoyl) benzoyl-ATP; P2X(7) RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; CEREBELLAR ASTROCYTES; NUCLEOTIDE RECEPTORS; CA2+ MOBILIZATION; CELLS; EXPRESSION; MICROGLIA; ATP; ACTIVATION;
D O I
10.1186/1471-2202-15-18
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The properties of Ca2+ signaling mediated by purinergic receptors are intrinsically linked with functional activity of astrocytes. At present little is known concerning Ca2+-dependent purinergic responses in adult human astrocytes. This work has examined effects of purinergic stimulation to alter levels of intracellular Ca2+ in adult human astrocytes. Ca2+-sensitive spectrofluorometry was carried out to determine mobilization of intracellular Ca2+ following adenosine triphosphate (ATP) or 3'-O-(4-benzoyl)benzoyl-ATP (Bz-ATP) stimulation of adult human astrocytes. In some experiments pharmacological modulation of Ca2+ pathways was applied to help elucidate mechanisms of Ca2+ signaling. RT-PCR was also performed to confirm human astrocyte expression of specific purinoceptors which were indicated from imaging studies. Results: The endogenous P2 receptor agonist ATP (at 100 mu M or 1 mM) applied in physiological saline solution (PSS) evoked a rapid increase of [Ca2+](i) to a peak amplitude with the decay phase of response exhibiting two components. The two phases of decay consisted of an initial rapid component which was followed by a secondary slower component. In the presence of Ca2+-free solution, the secondary phase of decay was absent indicating this prolonged component was due to influx of Ca2+. This prolonged phase of decay was also attenuated with the store-operated channel (SOC) inhibitor gadolinium (at 2 mu M) added to standard PSS, suggesting this component was mediated by SOC activation. These results are consistent with ATP activation of P2Y receptor (P2YR) in adult human astrocytes leading to respective rapid [Ca2+](i) mobilization from intracellular stores followed by Ca2+ entry through SOC. An agonist for P2X7 receptor (P2X7R), BzATP induced a very different response compared with ATP whereby BzATP (at 300 mu M) elicited a slowly rising increase in [Ca2+](i) to a plateau level which was sustained in duration. The BzATP-induced increase in [Ca2+](i) was not enhanced with lipopolysaccharide pre-treatment of cells as previously found for P2X7R mediated response in human microglia. RT-PCR analysis showed that adult human astrocytes in vitro constitutively express mRNA for P2Y1R, P2Y2R and P2X7R. Conclusion: These results suggest that activation of metabotropic P2YR (P2Y1R and/or P2Y2R) and ionotropic P2X7R could mediate purinergic responses in adult human astrocytes.
引用
收藏
页数:8
相关论文
共 33 条
  • [1] International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy
    Abbracchio, Maria P.
    Burnstock, Geoffrey
    Boeynaems, Jean-Marie
    Barnard, Eric A.
    Boyer, Jose L.
    Kennedy, Charles
    Knight, Gillian E.
    Fumagalli, Marta
    Gachet, Christian
    Jacobson, Kenneth A.
    Weisman, Gary A.
    [J]. PHARMACOLOGICAL REVIEWS, 2006, 58 (03) : 281 - 341
  • [2] Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells
    Adrian, K
    Bernhard, MK
    Breitinger, HG
    Ogilvie, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2000, 1492 (01): : 127 - 138
  • [3] Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons
    Anderson, CM
    Nedergaard, M
    [J]. TRENDS IN NEUROSCIENCES, 2006, 29 (05) : 257 - 262
  • [4] Pharmacological characterization of recombinant human and rat P2X receptor subtypes
    Bianchi, BR
    Lynch, KJ
    Touma, E
    Niforatos, W
    Burgard, EC
    Alexander, KM
    Park, HS
    Yu, HX
    Metzger, R
    Kowaluk, E
    Jarvis, MF
    van Biesen, T
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 376 (1-2) : 127 - 138
  • [5] RETRACTED: Signaling through P2X7 receptor in human T cells involves p56lck, kinases, and transcription factors AP-1 and NF-κB (Retracted Article. See vol 286, pg 9894, 2011)
    Budagian, V
    Bulanova, E
    Brovko, L
    Orinska, Z
    Fayad, R
    Paus, R
    Bulfone-Paus, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) : 1549 - 1560
  • [6] ATP: A ubiquitous gliotransmitter integrating neuron-glial networks
    Butt, Arthur M.
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2011, 22 (02) : 205 - 213
  • [7] P2X7 and P2Y13 purinergic receptors mediate intracellular calcium responses to BzATP in rat cerebellar astrocytes
    Carrasquero, Luz Maria G.
    Delicado, Esmerilda G.
    Bustillo, Diego
    Gutierrez-Martin, Yolanda
    Artalejo, Antonio R.
    Teresa Miras-Portugal, Ma
    [J]. JOURNAL OF NEUROCHEMISTRY, 2009, 110 (03) : 879 - 889
  • [8] Differential activation of subtype purinergic receptors modulates Ca2+ mobilization and COX-2 in human microglia
    Choi, HB
    Hong, SH
    Ryu, JK
    Kim, SU
    McLarnon, JG
    [J]. GLIA, 2003, 43 (02) : 95 - 103
  • [9] Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain
    Choi, Hyun B.
    Ryu, Jae K.
    Kim, Seung U.
    McLarnon, James G.
    [J]. JOURNAL OF NEUROSCIENCE, 2007, 27 (18) : 4957 - 4968
  • [10] EVANS RJ, 1995, MOL PHARMACOL, V48, P178